Disclosed are novel &agr;-aryl-N-alkylnitrone compounds and pharmaceutical compositions containing such compounds. The disclosed compositions are useful as therapeutics for preventing and/or treating neurodegenerative, autoimmune and inflammatory conditions in mammals and as analytical reagents for detecting free radicals.
本发明涉及新的&agr;-芳基-N-烷基亚
硝基化合物和含有这些化合物的制药组合物。所述组合物可用作治疗哺乳动物的神经退行性、自身免疫和炎症疾病的药物,以及用于检测自由基的
分析试剂。